Hepatitis C Virus 5′UTR Sequences That Bind eIF3 and Ribosomal 40S Subunits Confer Stimulation of Minus-Strand RNA Synthesis
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27073234 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Attiya Qadoos Malik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry, Faculty of Medicine, Justus-Liebig-University, 35392 Giessen, Germany. Hauptthemen laut MEDLINE: 5' Untranslated Regions, Hepacivirus, Eukaryotic Initiation Factor-3, RNA, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Hepatitis C Virus (HCV) is a plus-strand RNA virus that replicates its genome via a minus-strand intermediate, which in turn is the template for the synthesis of progeny plus-strand genomes. In order to characterize sequence elements in the HCV 5′-untranslated region (5′UTR) that are possibly involved in the regulation of minus-strand RNA synthesis starting at the genome’s 3′end, we used a replicon system in which a possible function of these sequences is uncoupled from other functions like translation regulation. For the specific detection by RT-qPCR of minus strands newly synthesized in the cells from the transfected replicon RNAs, we carefully eliminated the contaminating DNA and transfected RNA and avoided self-priming caused by hairpin formation. We found that the absence of any HCV sequences at the 5′end does not allow genome replication. Stem-loop I-II sequences only allow extremely low-level replication, whereas the presence of stem-loops I-III or the complete 5′UTR allows efficient replication. The mutation of sequences required for the binding of translation initiation factor 3 (eIF3) and the ribosomal 40S subunit in the 5′UTR of the plus strand severely impairs minus-strand synthesis. This suggests that eIF3 and the 40S subunit are involved in plus-strand 5′-3′-end communication and the regulation of minus-strand synthesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry, Faculty of Medicine, Justus-Liebig-University, 35392 Giessen, Germany.
- Institute for Virology, Faculty of Veterinary Medicine, Justus-Liebig-University, 35392 Giessen, Germany.
- Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Giessen, Justus-Liebig-University, 35392 Giessen, Germany.
- Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.
- University Children's Hospital, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
- Institute for Virology, Philipps-University Marburg, 35043 Marburg, Germany.
ORCID-Profile: Lyudmila Shalamova, Oliver Rossbach, Michael Niepmann
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Malik, A. Q., Shalamova, L., Khajouei, M., Budnik, J., Hell, A. L., Jost, E., Gerresheim, G. K., Rossbach, O., & Niepmann, M. (2026). Hepatitis C Virus 5′UTR Sequences That Bind eIF3 and Ribosomal 40S Subunits Confer Stimulation of Minus-Strand RNA Synthesis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27073234
Vancouver
Malik AQ, Shalamova L, Khajouei M, Budnik J, Hell AL, Jost E, et al. Hepatitis C Virus 5′UTR Sequences That Bind eIF3 and Ribosomal 40S Subunits Confer Stimulation of Minus-Strand RNA Synthesis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27073234
BibTeX
@article{Malik2026,
author = {Malik, Attiya Qadoos and Shalamova, Lyudmila and Khajouei, Mozhdeh and Budnik, Jonas and Hell, Anna-Lena and Jost, Elena and Gerresheim, Gesche K and Rossbach, Oliver and Niepmann, Michael},
title = {Hepatitis C Virus 5′UTR Sequences That Bind eIF3 and Ribosomal 40S Subunits Confer Stimulation of Minus-Strand RNA Synthesis},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27073234}
}
EUVIMED